Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1995 Aug;96(2):781-5.
doi: 10.1172/JCI118123.

Congenital human thyroglobulin defect due to low expression of the thyroid-specific transcription factor TTF-1

Affiliations
Case Reports

Congenital human thyroglobulin defect due to low expression of the thyroid-specific transcription factor TTF-1

A Acebrón et al. J Clin Invest. 1995 Aug.

Abstract

TTF-1 and Pax-8 are thyroid-specific transcription factors, from homeo and paired box genes, respectively, that are responsible for thyroid development and for thyroglobulin and thyroperoxidase gene expression. However, TTF-1 and Pax-8 preferentially bind to the thyroglobulin and thyroperoxidase promoters, respectively. Here, we have studied a patient with defective thyroglobulin synthesis. Thyroglobulin mRNA was found at very low levels while the mRNA for thyroperoxidase was found to be more abundant compared with control tissue. The low levels of thyroglobulin mRNA are caused by a transcriptional defect due to the virtual absence of TTF-1 expression as determined by Northern blot analysis, reverse transcriptase-PCR, and electrophoretic mobility shift assays. The level of Pax-8 mRNA was the same in the goiter and in the control thyroid. These results are the first reported evidence of a congenital goiter with a thyroglobulin synthesis defect due to the low expression of the thyroid-specific transcription factor TTF-1. Moreover, these data suggest that TTF-1 and Pax-8 would be differentially regulating thyroglobulin and thyroperoxidase gene transcription.

PubMed Disclaimer

References

    1. Mol Endocrinol. 1993 Dec;7(12):1589-95 - PubMed
    1. J Biol Chem. 1993 Nov 15;268(32):24125-37 - PubMed
    1. J Endocrinol. 1974 Mar;60(3):389-97 - PubMed
    1. FEBS Lett. 1982 Jan 25;137(2):189-92 - PubMed
    1. Science. 1985 Jul 26;229(4711):393-5 - PubMed

Publication types

MeSH terms